Intracellular delivery of proteins is an important barrier in the development of strategies to deliver functional proteins and protein therapeutics into the cells to realize their full potential in biotechnology, biomedicine, cell-based therapies, and gene editing protein systems. Most of the intracellular protein delivery strategies involve the conjugation of cell penetrating peptides to enable and enhance the permeability of plasma membrane of mammalian cells to allow proteins to enter cytosol. Small molecules conjugations such as (p-methylphenyl) glycine, pyrenebutyrate and cysteines are used for the same purpose. The molecular level interactions are governed mostly by ionic (cationic/anionic), covalent and non-covalent interactions with various molecular entities of glycocalyx matrix on plasma membrane lipid bilayer. Although the role of non-covalent interactions is not fully understood, it is intriguing to see the recent advances in the non-covalent interaction-based strategies of intracellular delivery of small molecules and proteins into mammalian cells. These are achieved by simple modification of proteins' surface with chemical moieties which can form non-covalent interactions other than hydrogen bonding. In this review, we describe the recent advances and the mechanistic aspects of intracellular delivery and role of non-covalent interactions during the cellular uptake of proteins and small molecules.
Read full abstract